These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9659853)

  • 1. Lithium discontinuation and subsequent effectiveness.
    Coryell W; Solomon D; Leon AC; Akiskal HS; Keller MB; Scheftner WA; Mueller T
    Am J Psychiatry; 1998 Jul; 155(7):895-8. PubMed ID: 9659853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study.
    Baldessarini RJ; Tondo L; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):551-3. PubMed ID: 9090345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors.
    Maj M; Pirozzi R; Magliano L
    Am J Psychiatry; 1995 Dec; 152(12):1810-1. PubMed ID: 8526252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The likelihood of recurrence in bipolar affective disorder: the importance of episode recency.
    Coryell W; Endicott J; Maser JD; Mueller T; Lavori P; Keller M
    J Affect Disord; 1995 Mar; 33(3):201-6. PubMed ID: 7790673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):548-50. PubMed ID: 9090344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.
    Faedda GL; Tondo L; Baldessarini RJ; Suppes T; Tohen M
    Arch Gen Psychiatry; 1993 Jun; 50(6):448-55. PubMed ID: 8498879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance.
    Viguera AC; Nonacs R; Cohen LS; Tondo L; Murray A; Baldessarini RJ
    Am J Psychiatry; 2000 Feb; 157(2):179-84. PubMed ID: 10671384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression as a lethal disease: prevention strategies.
    Coppen A
    J Clin Psychiatry; 1994 Apr; 55 Suppl():37-45. PubMed ID: 8077174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
    Suppes T; Baldessarini RJ; Faedda GL; Tohen M
    Arch Gen Psychiatry; 1991 Dec; 48(12):1082-8. PubMed ID: 1845226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine for treatment-refractory mania.
    Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
    Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.
    Judd LL; Schettler PJ; Akiskal HS; Coryell W; Leon AC; Maser JD; Solomon DA
    Arch Gen Psychiatry; 2008 Apr; 65(4):386-94. PubMed ID: 18391127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
    Maj M; Pirozzi R; Magliano L; Bartoli L
    Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lithium maintenance therapy in affective and in schizoaffective psychosis (author's transl)].
    Tress W; Haag H
    Nervenarzt; 1979 Aug; 50(8):524-6. PubMed ID: 119166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unsolved problems in the indications for lithium prophylaxis in affective and schizoaffective disorders].
    Angst J
    Bibl Psychiatr; 1981; (161):32-44. PubMed ID: 7271758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C; König B; Amann BL
    J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.